CTOs on the Move

AlloVir

www.allovir.com

 
AlloVir, formerly ViraCyte, was founded in 2013 and is the leader in the development of novel cell therapies with a focus on restoring natural immunity against life-threatening virus-associated diseases in patients with severely weakened immune systems.
  • Number of Employees: 25-100
  • Annual Revenue: $0-1 Million

Executives

Name Title Contact Details

Funding

AlloVir raised $120M on 05/23/2019

Similar Companies

Genetics Center

Genetics Center is a Orange, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Valo Health

Valo Health is a biotech company that is recreating the future of medicine.

Proclara Biosciences

Proclara is pioneering a new approach to treating neurodegenerative diseases. By developing novel therapies that recognize and target multiple misfolded proteins, we aim to make a transformative impact on the lives of patients affected by Alzheimer`s, Parkinson`s, and other diseases caused by protein misfolding. Our approach is shaped by an experienced team with deep drug development experience, and productive collaborations with world-class advisors and partners.

CerFlux

CerFlux Personalized Medicine aims to reduce the pain, reduce the discomfort, and reduce the cost of cancer treatment.

F1 Oncology

We are harnessing the power of the immune system to target some of the most challenging solid tumor malignancies.